Skip to main content
SpringerLink
Log in

Why the omega-3 piggy should not go to market

  • Correspondence
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hooper, L. et al. Br. Med. J. 332, 752–760 (2006).

    Article  CAS  Google Scholar 

  2. Kolata, G. Cloned pigs could provide meat that benefits the heart. New York Times (March 26, 2006). http://www.nytimes.com/2006/03/26/health/26cnd-pig.html

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Pennsylvania, Medical Ethics, 3401 Market St., Suite 320, Philadelphia, 19104, Pennsylvania, USA

    Autumn Fiester

Authors
  1. Autumn Fiester
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fiester, A. Why the omega-3 piggy should not go to market. Nat Biotechnol 24, 1472–1473 (2006). https://doi.org/10.1038/nbt1206-1472

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1206-1472

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation